Avicanna Inc. (” Avicanna ” or the ” Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that the failure-to-file cease trade order (the ” CTO “) issued by the Ontario Securities Commission on June 11, 2021 has been revoked effective September 10, 2021.
The Company will work with the Toronto Stock Exchange on a reinstatement of trading of its common shares, which were suspended from trading on June 11, 2021 as a result of the CTO.
The Company has filed the following periodic disclosure documents, bringing its continuous disclosure record up to date in accordance with applicable securities law:
- annual filings in respect of the year ended December 31, 2020, consisting of audited annual financial statements for the year ended December 31, 2020, management’s discussion and analysis relating to the audited annual financial statements for the year ended December 31, 2020, annual information form for the year ended December 31, 2020 and certification of the foregoing as required by National Instrument 52-109 - Certification of Disclosure in Issuers’ Annual and Interim Filings (“ NI 52-109 ”);
- interim filings in respect of the period ended March 31, 2021, consisting of interim financial statements for the period ended March 31, 2021, management’s discussion and analysis relating to the interim financial statements for...
Read Full Story: https://investingnews.com/daily/cannabis-investing/avicanna-announces-revocation-of-cease-trade-order/
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.